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1. Introduction 
Circulatory failure with no reaction to medical treatment requires urgent mechanical 
circulatory support to save the patient’s life and to open up the way for broader medical 
options. When ventricular assist devices (VAD) must be urgently implanted in patients 
suffering not only from hemodynamic shock but from the disastrous consequences of 
prolonged hypoperfusinon of vital organs, they are associated with high mortality. Good 
early and late outcome can be anticipated by the principle “good patient, good outcome.” In 
this sense a “good patient” for assist device implantation is one in whom the surgical 
procedure is undertaken in optimal time and not after the “zone of death” is reached, when 
the patient is suffering from multiorgan failure. Unfortunately optimal means of prognostic 
assessment of patients suffering from chronic circulatory failure are lacking. The available 
clinical guidelines are rather opened as a “road map” for the treatment until the treatment 
response is blunted and it is necessary to turn to the next step on this road. 
From our viewpoint it is necessary to distinguish between diagnostic means of helping to 
assess or even predict the transition from chronic compensated to acutely decompensated 
heart failure and the assessment of various factors as predictors of mortality. In other words 
acute precipitants such as rising left ventricular filling pressure, pulmonary rales etc. and 
physical signs[1] of congestive heart failure or even precipitants reflecting the conversion 
from a chronic compensated to a decompensated pathophysiological state do not necessarily 
help to set the indication for assist device implantation. These established factors today still 
lack reliability. The decompensation which “suddenly appears easy to treat” indicates that 
even acute worsening of chronic heart failure can be managed successfully by medical 
means. The important issue is to predict the risk of “true decompensation” (decompensation 
resistant to conventional treatment). The assessment of such factors is very valuable for 
estimating the optimal time-point for the implantation of mechanical circulatory support. 
Finding the optimal time also means that univentricular (usually left ventricular) support 
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may be sufficient. In such cases the outcome is better than with extracorporeal support of 
both ventricles. 
The goal of assessment of the “circulatory reserve” of the individual patient suffering from 
chronic circulatory failure is important; however the issue is very complicated. Until now 
such “factors” are unknown. More studies are needed to put together all known factors and, 
on the basis of statistical analysis, to extract “significant predictors influencing mortality.” 
There are several problems that should be taken into account here. 
Recent studies have suggested a multifactorial model containing many risk factors with 
statistical definition of their importance. The multifactorial risk model makes sense when 
the risk factors are correctly identified; otherwise, imprecise and misleading information can 
cloud the issue. The concept of setting a model with statistically prepared multirisk factors [2] 
as a “check list” is difficult to accept practically in clinical settings. Even separating the risks 
into precisely identified groups or goals (precipitating and predisposing) does not help 
clinicians to identify the best form of preventive intervention. 
By critical examination of such a multifactorial model at least the following conclusions 
have to be drawn: The systolic function of the left ventricle is no longer of value in 
predicting survival of the patients when profound systolic dysfunction has occurred[3,4]. The 
dynamic development of congestive heart failure (<12 month period)[5] is an important 
factor; however in the less malignant course the number of episodes of decompensation is 
truly important. Laboratory tests (sodium[6], BNP[7], noradrenalin level[8]) can help to 
identify individual patients possibly characterized by low reserve compensation 
mechanisms. The function of the right heart chamber and pulmonary pressure are factors 
that predict mortality, but their practical value – their value for the prediction of the life 
expectancy - is limited[9,10]. Continuous ambulatory monitoring on the basis of telemetric 
data transmitted by miniaturized technology[11] of the right-sided pressures[12] (for example 
the value of pulmonary pressure at time of closure of the pulmonary valve corresponds to 
the left filling pressure) can be used to detect the transition to decompensation and are 
therefore valuable in predicting risk (SENSE-HF trial,[13] CLEPSYDRA[14]). Continuous 
telemetric hemodynamic monitoring does not assess the circulatory reserves directly but 
rather informs the clinician that the physiological balance of the hemodynamics inside the 
circulation as a whole system has broken down. New criteria that could precisely predict the 
clinical state of the patients are badly needed to make the surgical decision for optimal 
timing of mechanical support in chronically ill patients. 
To understand the subject it is necessary to review the changing viewpoints on congestive 
heart failure. Congestive heart failure means chronic “circulatory failure” or “heart failure,” 
caused, for example, by end-stage dilated cardiomyopathy.  
1.1 Historical resumé 
The quality of the arterial pulse was first described as early as the sixteenth century by the 
Polish physician Josephus Struthius in his work Sphygmicae artis (published in Basel in 1555). 
His knowledge of the pulse is still utilized today (e.g. the distinction between pulsus altus, 
parvus, rarus, celler and durus) and is used not only to diagnose a heart pathology such as 
mitral stenosis or aortic incompetence but also for heart failure staging. Traditional 
understanding of systolic heart failure was based on invasive investigation performed on 
the basis of animal studies performed in 1879 in Berlin,[15] and diastolic function assessment 
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was undertaken at the beginning of the last century.[16] Heart function was regarded as of 
central importance on the way to understanding the pathology of circulation since the 
beginning of the era of modern medicine but the importance of the “circulation” was also 
pointed out. The state of “heart failure” was described in Latin as “stadio circulatoria 
suffitientiae relativae” or “circulatioria in stadio insuffitiantiae,” corresponding to the 
English expression, “congestive heart failure.” Traditionally the meaning of “congestion” 
was reserved exclusively for the venous vascular bed. Nevertheless, in addition to 
myocardial failure, circulatory congestion was taken to be an important part of the 
phenomenon called “heart failure.” The role of the “peripheral” circulation was seemingly 
forgotten. 
Nowadays the vascular resistance, as the representation of the circulation and especially of 
conduit physiology, appears rather more as a hemodynamic result of the heart function and 
the arterial system response. It is usually defined as the force of opposition known as 
“resistance” but not as an active and important functional unit that cooperates actively with 
the heart. However, the researchers and physicians dealing with mechanical circulatory 
support are recognizing the problem of circulatory failure but rather only semantically, 
writing of “mechanical circulatory support in heart failure.” Unfortunately this recognition 
is usually limited to expression and does not incorporate evidence-based medical factors of 
the importance of the circulation.  
1.2 Changing concept of the failing heart 
Reduction of left atrial loading conditions (preload) significantly alters the diastolic 
transmitral pressure relation and thus profoundly affects the Doppler flow velocity 
profile.[17] On the other hand the afterload also influences heart function. It is important to 
know how afterload affects preload in order to define the function of the extracardiac 
circulatory system. A.C. Guyton stated in 1955: “When a change occurs in the hemodynamics 
of the circulation system one cannot predict what will happen to the cardiac output unless 
to take in consideration both the effect of this change on the ability of the heart to pump 
blood and also on the tendency for blood to return to the heart from the blood vessels”[18]. 
This research produced a “volume pressure curve” of the systemic arterial and venous 
compartment which documents the interplay between venous pressure and volume in 
arterial and venous segments in dependence on stimulation or inhibition[19]. On the other 
hand the venous return influences the atrial pressure and consequently cardiac output 
(Guyton diagrams)[20], not to forget that venous return is regulated by the arterial system. 
Briefly, the pumping ability of the heart depends mostly on the venous return if the 
diseased heart is in stable condition after a destructive process has been healed. It should be 
stated that not the worsening of the failing myocardiac function but rather circulatory 
dysfunction during the chronic phase is the cause of worsening of the circulation as a whole. 
The monitoring of the arterial and venous compartment can help to define the 
hemodynamic condition and find predictors of the final event of decompensation.  
The arterial part of the circulation (arterial conduit) is easy to access and, being situated 
between the venous compartment and heart function, not only has the passive function of 
conduction of the blood but is an active part of the circulation. 
In normal human beings the heart can mobilize reserves so that the cardiac output can rise 
five times, for example from 6 l/min to 30 l/min in athletes. The severely diseased heart is 
www.intechopen.com
 New Aspects of Ventricular Assist Devices 
 
6 
hardly able to raise cardiac output by more than 10%. The arterial tree can change the 
distribution of perfusion, depending on the acute need, to supply the more important organs 
and let other organs “hibernate.” The physiological process known as “preconditioning” is 
responsible for the smoothly functioning economy of the body with a constant lack of 
oxygen. The circulation, and especially the arterial compartment, demonstrates abnormal 
vascular response to volume unloading when the heart is failing.[21] This implies that the 
arterial conduit is responsible for decompensation and is the key to stabilizing the 
circulation and to describing diagnostically its function and dysfunction. Virtually speaking 
there is the level of arterial conduit dysfunction beyond which compensation is not possible; 
below these levels “true” decompensation is only a matter of time. This concept of 
congestive heart failure is the clue to understanding the transition from the compensated to 
the decompensated state in patients suffering from heart failure. 
1.3 Arterial conduit function 
The left ventricle mechanically loads the systemic circulation in a pulsated manner. In 
abnormal LV function the circulation is supplied under special conditions determined by 
the autonomic properties of the vascular bed.  
The influence of the arterial system on the heart as a pump in congestive heart failure is 
seldom presented in the literature; it is more often studied as its own unit of interest that 
responds to different deconditioning mechanisms.[22,23,24] Although the importance of pulse 
and blood pressure is always studied in hypertensive patients, the relation between the 
effect of the left chamber work, defined as stroke, and the arterial tree has not been 
adequately recognized. This may be the essential key to heart failure pathophysiology.  
There are several methods of defining the active operation of the arterial conduit (large and 
small resistance arteries) interacting directly with the heart ejection. One of the simplest and 
most commonly applied to determine the stage of cooperation between the heart and the 
arterial system is invasive or non-invasive measurement of pressure in one of the branches 
of the arterial system. The pressure measured is the main criterion for diagnosis of acute 
heart failure (vasoactive shock). In recent years the importance of systolic pressure as a 
predictor of mortality in patients with acute and chronic[25] forms of heart failure has been 
recalled. Low pressure in patients suffering from chronic forms of heart failure is recognized 
as a positive prognostic factor of mortality. However, the explanation of this phenomenon is 
based rather on a monotheory that failure of the heart (low cardiac output) may play a first 
role[26] (partial truth), but not that dysfunction of the arterial conduit - as an interactive 
organ - may also be involved in the state of “circulatory failure.” Nevertheless there exists 
agreement that the result of interaction of the heart and arterial conduit - blood pressure - is 
an important prognostic factor for assessing the risk of mortality in acute and chronic forms 
of “heart failure.”  
Additional information on the circulatory state may be based on investigation of the 
relationship between cardiac output and blood pressure by a formula called the “cardiac 
power”[27] or “circulatory power” during peak exercise in stable patients.[28] The pumping 
power of the heart is determined as the product of cardiac output (simultaneously 
measured) and mean arterial pressure. 
A study of patients suffering from acute forms of heart failure, especially those with ejection 
fraction of below 40%, has documented that systolic blood pressure was linearly and 
inversely associated with mortality.[27] 
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1.3.1 Windkessel model 
Any part of the cardiovascular system, when it is compliant, possesses a volume reserve 
according to needs. The arterial windkessel model is based on a “system of tubes” as a 
representation of the arterial tree and allows analysis of the resistance and compliance of the 
arterial conduit.  
1.3.2 Pressure-flow analyses in the time domain  
Accurate non-invasively measured central arterial pressure and flow in large arteries 
available for investigation (e.g. the carotid artery) can be used for pressure-flow analysis. 
Using computational equipment to analyze both signals (pressure and flow) gives unique 
possibilities to assess interaction of the diseased heart and the arterial conduit. One method 
based on this principle is wave intensity (WI) measurement. 
2. Wave intensity  
The concept of wave intensity is based on simultaneous computerized analysis of the blood 
ejected into the arterial conduit, which causes the phenomenon of interaction of flow (the 
velocity of the stroke volume) with the flow mechanics inside the studied vessel and the 
interaction of pressure and compliance of the vessel. The simultaneous study of flow and 
pressure interaction enables WI assessment. 
To understanding the whole concept it is necessary to review shortly the basic physiology of 
heart ejection as a function of the whole circulation. The early phase of ejection is 
characterized by a positive pressure gradient in the left ventricular outflow tract (LVOT) 
and a rise in both pressure and flow in the ascending aorta. After this phase the pressure 
still rises but the flow falls. During approximately the last third of ejection there is a negative 
pressure gradient in the LVOT and ejection persists, while flow and pressure fall until the 
aortic valve closes. Ejection occurs because the momentum of the blood shifts the last part of 
the stroke against higher pressure above the aortic valve.  
It has to be remembered that the pressure difference between the LVOT and ascending aorta 
is negative late in systole (during 2nd wave building). The ejection of blood into the aorta 
during this time results from the momentum of the ejected blood.[29] This phase is 
characterized by gentle relaxation of the myocardium[30] – leading to a smooth return of the 
muscle function from contraction to relaxation. The effect of this cooperation “gently” stops 
the back blood flow (before aortic valve closure) and again it should be stated that the 
relation of flow and pressure is directly related to the blood momentum but also to the 
diastolic quality of the heart muscle, which defines diastolic function of the heart before 
aortic valve closure (traditionally taken as the event signalling the relaxation period).  
Invasive wave intensity (WI) index is well described by Parker et al.[31] and is primarily 
calculated from invasive parameters as the product of the derivatives of the simultaneously 
measured pressure and velocity inside the artery: 
WI= (dP/ dt)  (dV/ dt) 
where P= pressure and V= flow. 
The non-invasive simultaneous analysis of pressure change and flow signals sampled 
during short constant intervals (5 ms) can be used for real-time non-invasive WI (NWI) 
analysis.  
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The waveform of carotid wall displacement (dU) closely corresponds to pressure change 
(dP) in a carotid artery measured invasively with high correlation quotient (goodness of fit 
r²=0.97) and can be substituted for the invasively recorded pressure waveform.[32] This study 
by Sugawara et al. has opened up the way to the assessment of NWI, because high fidelity 
pressure and flow signals are easily obtainable by ultrasonic investigation. Non-invasive 
wave intensity (NWI) is defined on the basis of echocardiography[33] (ALOKA Ultrasonic 
System, Japan). The formula for NWI is as follows: 
NWI= (dU/ dt)  (dV Doppler/ dt) 
where dU = difference in displacement of carotid artery and V = flow velocity measured by 
Doppler. 
 
WI 1st WI 2nd
ΔU mmHg
Flow vel..
T
 
Fig. 1. The noninvasive WI index assessed in a normal subject. The yellow curve of WI 
consists of two peaks (1st and 2nd). The 1st peak is the “compression wave” and the 2nd peak 
the “expansion” wave. The pressure (red curve) is marked “ΔU mmHg” and flow waveform 
(green curve) “flow vel.”. The wave T is marked by a white arrow 
The NWI index materializes as the curve consisting of two mathematically defined peaks (1st 
and 2nd). The 1st peak is the “compression wave” and is mathematically positive as a product 
of two positive values of first derivatives of pressure and flow waveform as demonstrated 
mathematically (Fig. 1). The compression wave of the 1st peak of WI describes the state of 
myocardial contractility of the LV in relation to the afterload. At the end of isovolumic 
contraction (which is the beginning of the 1st peak) the LV pressure becomes equal to aortic 
diastolic pressure which indicates that the LV begins to challenge the afterload force.[34] The 
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height of the peak is directly related to LV contractility and to stroke volume at a given 
afterload. This parameter reflects very tiny differences in ejection dynamics and stroke 
volume (at given/constant afterload) and can be used as a marker of circulatory reserves but 
also as a versatile marker in many clinical situations. The 2nd peak is created during the 
negative pressure gradient in the LVOT and is influenced by the momentum of the blood 
ejected into the aorta. The value of momentum of blood ejection in the last phase of ejection 
is connected to relaxation of the LV. Simplifying the physiological dispute, this means that 
during ejection the blood is stopped by the gentle slowing of the LV ejection during the last 
part of ejection (when the pressure in the LV chamber is lower than in the aorta), which 
reflects the idea of relaxation of the LV myocardium, as was experimentally documented by 
Solomon.[35] This explains why the 2nd peak is related to the relaxation of the myocardium 
which begins before aortic valve closure. 
 
 
Fig. 2. The noninvasive WI (yellow curve) from a patient suffering from end-stage dilated 
cardiomyopathy during “true decompensation“. Note that the green curve represents 
pressure and the red curve represents flow 
Returning to the second phase of ejection, it is necessary to describe the negative part of WI 
appearing as the continuation of the 1st peak and named negative T wave (Fig. 1). The T 
wave is formed by the negative product of pressure and flow (dU / dt)  (dV / dt) where 
pressure is still rising and flow is diminishing (mixed mathematical factors reflected as 
negative product). 
During WI investigation several parameters are obtainable: negative area T, arterial stiffness 
as beta value (β), diameter of the artery studied, minimal and maximal flow in the artery 
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and dynamic changes in real time of several other parameters. The T wave was not found to 
have prognostic importance in our studies.  
The 2nd peak of WI (“expansion wave”) is calculated in the same way as the 1st peak, which 
means that it is the result of algebraically calculated pressure and flow inside the vessel after 
ejection. While both curves (pressure and flow) in this phase are negative, algebraically their 
derivates produce a positive 2nd peak of WI. In general this peak defines diastolic function of 
the heart (active relaxation of the myocardium in systole) and the diastolic function of the 
conduit (elastic properties, filling of the conduit, which is similar to LV filling). The 2nd peak 
is usually smaller than the 1st but in pulsus alternans or in a situation of passively overfilled 
arterial conduit (with any kind of rotary pump support) it can be higher than the 1st peak if 
the heart possesses native ejection.  
2.1 Human studies 
2.1.1 Influence of alternant beat (reduced contractility) on wave intensity (type A 
pathology of myocardial failure)  
The pathophysiology of pulsus alternans is diverse and there are several theories that are 
used to explain this phenomenon. Although description of all these theories is not necessary 
for this purpose, it is important to note that the majority of considerations are based on 
myocardial, electrical and hemodynamic functional components. The myocardial theory is 
based on the alteration of diastolic prosperities of myocytes of the diseased heart[36,37], 
whereas the electrical alternans theory[38] is based on the primary alteration of electrical 
stimulation, secondarily influencing myocardial reaction. The hemodynamic theory explains 
“weak beats” on the basis of worse filling of the chamber (loading conditions) and alteration 
of the Frank-Starling curve. Independently of different theories that could explain the 
pathology of pulsus alternans the one beat is strong (“normal” for studied individual) and 
the second is weak. In other words the stroke volume is alternately normal and smaller, 
causing normal pulse quality, and the second beat is weak and recognizable on the blood 
pressure curve or by studying the pulse in any other way. It is well documented that 
pressure in late diastole rises more slowly in the weak beat, which has to interpreted by an 
alteration in diastolic compliance[39].  
Figures 3 A and B demonstrate WI applied in an ambulatory patient suffering from DCM at 
the stage of NYHA III and having pulsus alternans (3B). WI peaks from “strong” (3A) and 
“weak” (3B) beats identify the hemodynamics of the composite of the heart and arterial 
conduit in this individual. The 1st (Fig. 3A, white arrow) and second WI peak (Fig. 3A, red 
arrow of the “strong beat” are typical findings in heart failure patients. The 1st WI peak is 
small but the 2nd peak is relatively higher than in normal individuals and is responsible for 
the quotient of relation of the 1st to the 2nd peak being 2:1 (1st 3441 to 2nd 1834 mmHg*s³), 
whereas in normal persons it is usually 6:1. 
The second beat is “weak” and is produced by suboptimal stroke volume (Fig. 3B) influencing 
the pulse curve peak (P) which is smaller and rises more slowly. The simultaneously recorded 
flow (F) curve also rises more slowly, so that the 1st peak of WI as a product of the derivatives 
of pressure/flow (dU/ dt)  (dV / dt) is reduced to 50% of the previous strong beat. The 2nd 
peak is preserved and both peaks are at the level of 1800 mmHg*s³. The high 2nd peak of WI is 
exemplified by a negative and sharp fall in the product of the derivatives pressure and flow 
recorded simultaneously. An explanation of the reduction of the 1st and preservation of the 2nd 
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peak of WI helps us to understand the importance of WI as a tool defining hydraulic 
cooperation of the arterial conduit and the heart. The lower and less “dynamic” the early 
ejection phase, the lower the 1st peak for given compliance of the conduit is. The 2nd peak of WI 
illustrates and defines the level of the conduit filling (see next subsection), the value of ejected 
blood momentum during the 3rd phase of ejection, and compliance of the chamber at the end 
of systole before aortic valve closure. This 2nd peak is inversely related to diastolic compliance 
of the LV and inversely related to the state of filling of the conduit (see below). 
 
 
Fig. 3. Noninvasive WI in a patient suffering from end-stage dilative cardiomyopathy who 
has pulsus alternans. A: strong beat; B: weak beat. P= pressure curve. F= flow curve. White 
arrow 1st and red arrow 2nd peak of WI. EKG= electrocardiogram 
2.1.2 Mixed pathology of arterial volume overloading and systolic heart dysfunction 
influences wave intensity (type B pathology) 
The clinical picture of congestive heart failure when arterial congestion is present can be 
illustrated by the case of a patient who suffered from acute myocardial infarction 
complicated by cardiogenic shock 7 days after successful revascularization during Impella 
mechanical circulatory support (Fig. 4A). This is a schematic representation of arterial filling 
during Impella support with flow of 3.5 l/min and native stroke volume of the heart of only 
20 ml. Because the LV chamber is partially unloaded (filling pressure only 7 mmHg) the 
stroke volume is low and reaches only the level of 20 ml. The 1st peak is low (approx. 5500 
mmHg*s³) and produced by slowly rising pressure and simultaneous slowly rising flow 
curve during the first phase of systole (Fig. 5A). The 2nd peak is high (approx. 8800 
mmHg*s³) and produced by sharply falling pressure and flow (even below the zero line) 
during the last phase of systole. The diameter of the artery was significantly larger than 
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during reduced Impella flow (6.93±1.39 vs. 6.45±1.97 mm respectively, p = 0.003). Reduced 
systolic function of the diseased heart and unloading defined by the Starling principle 
reflect type 1 pathology (“weak” beat of pulsus alternans) and is responsible for low 1st 
peak. The 2nd peak of WI is not proportionally higher, reflecting severe diastolic dysfunction 
and arterial overloading. During the procedure of weaning from Impella there are 
important alterations in the loading conditions of the heart and arterial conduit (Fig. 4B). In 
this stage, when the pump did not significantly fill the arterial conduit (0.2 l/min) the 
patient was treated with high doses of epinephrine and the heart was driven by adequate 
filling for this state of disease (PCP 18 mmHg), producing stroke volume of 40 ml. 
The value and relations of peaks during spontaneous heart function (with maximal Impella 
support the heart did not possess sufficient filling to eject) is presented in Fig. 5B. The 1st 
peak was high (approx. 21,000 mmHg*s³.) after medical support and the second was higher 
than normal (approx. 3800 mmHg*s³). High 2nd peak can be explained by high negative flow 
in the conduit and a rapid fall in the pressure curve before aortic valve closure. These 
phenomena are mainly due to rapid vanishing of the value of momentum of blood, 
reflecting reduced compliance of the heart muscle after infarction. The 2nd peak is inversely 
related to the diastolic compliance of the LV (and all parameters influencing myocardial 
compliance). Again this experimental study demonstrates that 1st peak is related to systolic 
function of the heart in relation to arterial conduit function. The 2nd peak defines diastolic 
function of the LV chamber and the filling state of the arterial conduit.  
 
 
Fig. 4. Schematic drawing of the heart chambers and aorta (Ao) during different stages of 
seventh day Impella support in a patient following successful surgical revascularization, 
suffering from heart infarction complicated by cardiogenic shock. A: Impella (Ip) low 3.5 
l/min (stage A); B: Impella flow (Ip) 0.2 l/min (stage B). Blue arrows indicate aortic 
dimension (Ao) dependent on Impella support. Black arrows indicate LV dimension 
dependent on Impella support. LA = left atrium, RA = right atrium, RV = right ventricle,  
SV = stroke volume, PCP = pulmonary capillary pressure 
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Physiological cooperation between the chambers and the arterial conduit means that under 
a given filling pressure of both sides adequate systolic performance is maintained in changing 
circumstances (resistance, preload, afterload) which can be monitored noninvasively by WI. 
One can hypothesize that these two types of pathology (A, primary myocardial dysfunction 
and B, myocardial dysfunction and volume shift into the arterial conduit, responsible for 
congestion) are probably the icons of the daily clinical situations in patients suffering from 
end-stage congestive heart failure.  
 
 
Fig. 5. The noninvasive WI 1st and 2nd peak (WI curve) assessed in the patient represented in 
Fig. 4, during stage A and B of Impella support. The scale is the same for A and B.  
P = pressure, V = flow, SV = stroke volume, PCP = pulmonary capillary pressure 
2.1.3 Effect of posture on wave intensity 
WI studies in humans suffering from circulatory failure are limited to a small number of 
centers.[40] In 2001 we first studied 31 patients suffering from end stage DCM[41] to assess 
circulatory reserves by utilizing a simple tilting test moving patients from supine to upright 
position. When DCM patients moved from supine to upright position, the filling of the 
venous bed was reduced (the overdistended jugular vein was collapsed) and filling of the 
heart chambers was therefore also reduced. Changed preload and afterload forces 
influenced the mitral filling pattern of the failing myocardium as well, as recorded by 
pulsed Doppler. The E wave (early filling or spontaneous filling) was significantly reduced 
(0.7±0.22 vs 0.4±0.19 m/s, p=0.001) and the A wave (atrial kick) was unchanged (0.5±0.15 
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m/s vs 0.5±0.10). This alteration significantly influences in a negative manner the stroke 
volume (p=0.05) but not WI parameters. The 1st and 2nd peak were not significantly higher in 
standing than in supine position (1st 4606±2283 vs 5405±2432 and 2nd 1483±675 vs 2002 ±726 
mmHg*s³, both ns). The conclusion should be drawn that in patients suffering from chronic 
systolic and diastolic myocardial failure the acutely provoked hemodynamic imbalance of 
preload and afterload influences SV negatively, but this alteration was corrected by 
mechanical cooperation of the arterial conduit to keep adequate conditions in the circulation 
system. Therefore the wave intensity marker is helpful by providing information not only 
about LV systolic function but also about the mechanoelastic prosperities of the arterial 
system integrated with the elastic prosperities of the myocardium responsible for 
hemodynamic homeostasis. 
 
2.1.4 Wave intensity as a prognostic marker 
The next study at the Deutsches Herzzentrum Berlin (DHZB, German Heart Institute Berlin) 
was performed in a prospective manner to establish the utility of WI as a predictor of life 
expectancy. A cohort of 151 consecutive outpatients (age 48.7±12 years; 110 men) with end-
stage DCM was prospectively studied. The follow-up period of patients was 31±8 months. 
End-points were death, life-saving circulatory support, and urgent transplantation. 
During the follow-up 44 patients were lost; there were 15 cardiac deaths (10%), life-saving 
ventricular assist device implantation in 10 (6.6%) and transplantation in 19 (12.7%). The 
most accurate predisposing factor for events (death, assist device implantation and urgent 
transplantation) in ambulatory patients was low 1st peak (OR 45.6, CI 14.5-143.3, p<0.001) 
(Fig. 1). The “cut-off value” for 1st peak assessed on the basis of our study was set at the 
level of <4100 mmHg*s3[42]. Less powerful predictors of the risk of deterioration were: low 
quotient of 1st to 2nd peak relation, left sided filling pressure (PCP), diastolic PAP and E/A 
mitral wave ratio (p=0.05 for all). Left ventricular ejection fraction (LVEF) and LV diameter 
did not show statistical significance for this purpose.  
Figure 6 shows the event-free cumulative survival of ambulatory patients (n=151). This 
curve does not represent a pure survival curve because patients who were removed from 
this curve do not represent those who died, while this group includes those who were saved 
by transplantation or VAD implantation as well as those who died. Patients accepted in this 
way and regarded as “event free” represent those who were hemodynamically stable. In 
other words, the group of patients designated “event positive” were lost for the purposes of 
our study not only because of death but also because of hemodynamic instability or 
hemodynamic and clinical worsening; these patients could not be stabilized with medical 
means but required assist device implantation or urgent transplantation. 
 
3. Discussion 
The usual and until now most plausible explanation for unexpected or unpredicted 
worsening (transition) into “true decompensation” was based on primary systolic or 
diastolic myocardial failure[43,44]. In the list of probable predictors the arterial part of the 
circulation has been ignored as a possibly important issue where “unknown” factors could 
be hidden. This has led to limited interest and little evidence-based research regarding the 
function of the arterial system in the presence of the “failing heart”; however, the concept of 
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a causal relation between the heart and arterial conduit failure[45] is an important topic.  
It should be kept in mind that the arterial tree functions as a “conductor” and plays a vital 
role as an active transmitter of blood to the peripheral tissue. The reactivity of the arterial 
system to any kind of physiological stimulation is well known from animal studies and can 
negatively influence study results.[46] However, patients suffering from congestive heart 
failure in general and especially from the advanced stages of the disease are very stable 
(blunted reactivity) and do not demonstrate variability of WI parameters from beat to beat. 
This method was validated and demonstrated good reproducibility in human beings.[47]  
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Fig. 6. “Event free” cumulative survival for ambulatory patients (n=151) divided into two 
groups according to the development of 1st peak WI. Survival of patients possessing WI 1st 
peak >4100 mmHg*s³ (green curve); survival with the peak <4100 mmHg*s³ (blue curve). 
The cut-off value of 4100 mmHg*s³ was established empirically by studying the group of 
patients during “true decompensation” 
3.1 Wave intensity parameters studied in carotid artery as predictors of hemodynamic 
deterioration 
Although NWI was assessed in the carotid artery it defines the cooperation of the heart with 
the arterial conduit (aorta and arterial system) as a whole and not exclusively the arterial 
system of the heart. This is the law of “connected compartments” (vessels). Our results 
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documented the true importance of WI assessment in defining lack of circulatory reserves, 
although for patients in whom heart dysfunction is present the “extracardiac” factors may 
play an important role in driving the patient to progressive decompensation. It has been 
hypothesized by others that elevated filling pressure may secondarily cause heart dysfunction 
but not always be the result of the loss of myocardial performance[48]. Changes in afterload 
are common physiological reactions of the highly sensitive arterial segment of circulation. 
The left ventricle “meets” directly the afterload at the end of isovolumic contraction, when 
the left ventricular pressure becomes equal to the aortic diastolic pressure, as stated by M. 
Katz. The pressure–volume relationship is strongly dependent on afterload. Increasing the 
afterload reduces the stroke volume of the diseased heart by increasing the pressure 
throughout ejection. On the contrary, decreasing the afterload reduces left ventricular 
pressure during ejection and increases stroke volume.[49] In other words overloading of the 
arterial conduit (e.g. by volume shift or sympathetic stimulation) can lead to backward LV 
loading above the tolerance of the diseased heart, causing smaller stroke volume. This 
diminution of stroke volume is difficult to assess but WI 1st peak reduction is significant. 
Hypervolemic episodes which lead to an afterload rise above the control ability of the 
diseased myocardium, do not necessarily mean simple volume overload but may represent 
an inter-compartment volume shift inside the circulation.[50] Newly published data supports 
the hypothesis that “hypervolemic episodes” are produced by volume shift in patients 
suffering from chronic heart failure rather than by simple external “over-supplementation.” 
The study by Zile and coworkers[12] documented that the transition from compensation to 
decompensation in a group of patients suffering from chronic systolic heart failure was not 
bound with body weight gain and that the development of pulmonary edema was due to 
volume shift from one compartment to the other. Whether it was a backward or forward 
shift is a matter of debate. Failing interaction of the heart chambers caused by blunted 
vasoreflexes can cause pulmonary edema. If the right atrial filling alters in the sense that the 
RV increases stroke volume by only 5 ml per beat, then the LV chamber attempts to increase 
the stroke volume also but, if this is not possible, after 100 beats the lungs will be 
overloaded. On the other hand rising afterload of the LV can cause LV depression which is 
described as “backward” failure. The rise in afterload does not necessarily need to be 
connected to an arterial pressure rise but may be related to volume shift in a mechanism of 
reduced peripheral perfusion, as partially documented in our type B failure.  
4. Conclusion 
It can be hypothetically stated that heart disease is responsible for the physiological state 
known as heart failure but that worsening of the heart failure or recompensation should be 
considered dysfunction of the arterial segment of the cardiocirculation. 
In general these theories support the explanation of the results of our study that cooperation 
between the failing heart and the arterial conduit can be an important and until recently 
“unknown factor” for outcome prediction in patients suffering from congestive heart failure. 
As we assumed, some research indicates strongly that diastolic function of the heart may be 
reflected in the 2nd peak[51]; this could also be interpreted as relaxation dysfunction of the 
LV myocardium, as we discussed in the description of “type B” pathology. In this respect 
WI (2nd peak) defines the diastolic function of the heart during the early phase of relaxation. 
However, in our study the 1st peak was found to be the most significant (p<0.001) prognostic 
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factor of final hemodynamic deterioration, and this factor can be utilized in surgical 
decision-making for assist device implantation.  
We conclude that the new ventricular-arterial coupling WI parameters assess heart-arterial 
conduit function. The study of arterial conduit function is promising for the prognostic 
assessment of patients suffering from heart failure and can help to define the optimal timing 
for mechanical circulatory support. 
Literally the WI 1st peak can potentially be used to distinguish patients at high risk for true 
deterioration and death. High 2nd peak is related to severe diastolic heart failure and 
overvolumed arterial bed during the conversion from compensation to decompensation. 
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